Process for the preparation of morpholine derivatives and intermediates therefore

Details for Australian Patent Application No. 2003226760 (hide)

Owner GLAXO GROUP LIMITED

Inventors Walker, Andrew John; Mills, Gail; Swanson, Stephen; Hayes, Martin Alistair; Wilkinson, Mark

Agent Phillips Ormonde Fitzpatrick

Pub. Number AU-A-2003226760

PCT Number PCT/EP03/03343

PCT Pub. Number WO2003/082835

Priority 0207450.8 28.03.02 GB

Filing date 27 March 2003

Wipo publication date 13 October 2003

International Classifications

C07D 265/30 Heterocyclic compounds containing six-membered rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms

Event Publications

7 August 2003 Complete Application Filed

  Priority application(s): 0207450.8 28.03.02 GB

20 November 2003 Application Open to Public Inspection

  Published as AU-A-2003226760

5 April 2007 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(a). A direction to request examination has been given for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2003226761-Benzenesulphonate salt of a morpholine urea derivative for use as a CCR-3 antagonist the treatment of inflammatory conditions

2003226759-MORPHOLINE DERIVATIVES SUBSTITUTED AT THE 2-POSITION BY AN ARYLALKYLUREA GROUP FOR USE AS CCR-3 ANTAGONISTS IN THE TREATMENT OF INFLAMMATORY CONDITIONS